Friedrich Marks

9.8k total citations · 1 hit paper
222 papers, 8.1k citations indexed

About

Friedrich Marks is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Friedrich Marks has authored 222 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Molecular Biology, 45 papers in Pharmacology and 40 papers in Genetics. Recurrent topics in Friedrich Marks's work include Protein Kinase Regulation and GTPase Signaling (40 papers), Inflammatory mediators and NSAID effects (39 papers) and Estrogen and related hormone effects (33 papers). Friedrich Marks is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (40 papers), Inflammatory mediators and NSAID effects (39 papers) and Estrogen and related hormone effects (33 papers). Friedrich Marks collaborates with scholars based in Germany, United States and France. Friedrich Marks's co-authors include Gerhard Fürstenberger, Michael Gschwendt, Walter Kittstein, Karin Müller‐Decker, Gabriele Rincke, Peter Krieg, E. Hecker, H.-J. Müller, Rukun Zang and Friedemann Horn and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Friedrich Marks

218 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rottlerin, a Novel Protein Kinase Inhibitor

1994 779 citations Michael Gschwendt, Walter Kittstein et al. Biochemical and Biophysical Research Communications profile →

Peers

Countries citing papers authored by Friedrich Marks

Since Specialization

Citations

This map shows the geographic impact of Friedrich Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedrich Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedrich Marks more than expected).

Fields of papers citing papers by Friedrich Marks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedrich Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedrich Marks. The network helps show where Friedrich Marks may publish in the future.

Co-authorship network of co-authors of Friedrich Marks

This figure shows the co-authorship network connecting the top 25 collaborators of Friedrich Marks. A scholar is included among the top collaborators of Friedrich Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedrich Marks. Friedrich Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cellular Signal Processing 2017 ·Friedrich Marks, Ursula Klingmüller, Karin Müller‐Decker	29
2	Inhibition of Cell Proliferation by Bacterial Lipopolysaccharides in TLR4-Positive Epithelial Cells: Independence of Nitric Oxide and Cytokine Release 2005 ·Journal of Investigative Dermatology ·Karin Müller‐Decker, Gwendolin Manegold‐Brauer, (unknown), (unknown), (unknown), Kathleen Richter, (unknown), (unknown), Friedrich Marks	16
3	Cyclooxygenase-2 and Skin Carcinogenesis 2003 ·PubMed ·(unknown), Friedrich Marks, (unknown)	9
4	Mouse Skin as a Model for Cancer Chemoprevention by Nonsteroidal Anti-Inflammatory Drugs 2003 ·Recent results in cancer research ·Friedrich Marks, Gerhard Fürstenberger, Gitta Neufang, Karin Müller‐Decker	17
5	Cyclooxygenase-2: A Molecular Target For Chemoprevention Of Epithelial Tumors Of Skin And Colon 2002 ·Advances in experimental medicine and biology ·Karin Müller‐Decker, (unknown), (unknown), (unknown), Friedrich Marks, Gerhard Fürstenberger	3
6	The Effects of Cyclooxygenase Isozyme Inhibition onIncisional Wound Healing in Mouse Skin 2002 ·Journal of Investigative Dermatology ·Karin Müller‐Decker, (unknown), Friedrich Marks, Gerhard Fürstenberger	61
7	Der Stoffwechsel der Arachidonsäure 2000 ·Biologie in unserer Zeit ·Friedrich Marks	0
8	Cancer chemoprevention through interruption of multistage carcinogenesis 2000 ·European Journal of Cancer ·Friedrich Marks, Gerhard Fürstenberger	92
9	Prostaglandins, leukotrienes, and other eicosanoids : from biogenesis to clinical applications 1999 ·Wiley-VCH eBooks ·Friedrich Marks, Gerhard Fürstenberger	24
10	Metabolic Targets of Cancer Chemoprevention: Interruption of Tumor Development by Inhibitors of Arachidonic Acid Metabolism 1999 ·Recent results in cancer research ·Friedrich Marks, Gerhard Fürstenberger, Karin Müller‐Decker	31
11	Arachidonic Acid Metabolism in Primary Irritant Dermatitis Produced by Patch Testing of Human Skin with Surfactants 1998 ·Toxicology and Applied Pharmacology ·Karin Müller‐Decker, (unknown), Gerhard Fürstenberger, Ambrus Kecskés, Wolf‐Dieter Lehmann, Friedrich Marks	32
12	Relationship between TGFα-induced DNA synthesis and prostaglandin synthesis in human HaCaT keratinocytes 1996 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), Gerhard Fürstenberger, Friedrich Marks	31
13	Expression of Growth Arrest-Specific (Gas) Genes in Murine Keratinocytes: Gas2 Is Specifically Regulated 1996 ·Experimental Cell Research ·(unknown), Claudio Brancolini, Friedrich Marks, Karsten Richter	13
14	Mechanisms in tumor promotion: guidance for risk assessment and cancer chemoprevention 1995 ·Toxicology Letters ·Friedrich Marks, Gerhard Fürstenberger, (unknown), Karin Müller‐Decker	16
15	Keratinocyte-Derived Proinflammatory Key Mediators and Cell Viability as in Vitro Parameters of Irritancy: A Possible Alternative to the Draize Skin Irritation Test 1994 ·Toxicology and Applied Pharmacology ·Karin Müller‐Decker, G. Fürstenberger, Friedrich Marks	57
16	Protein kinase C activation by phorbol esters: do cysteine-rich regions and pseudosubstrate motifs play a role? 1991 ·Trends in Biochemical Sciences ·Michael Gschwendt, Walter Kittstein, Friedrich Marks	107
17	A phorbol ester and phospholipid‐activated, calcium‐unresponsive protein kinase in mouse epidermis: Characterization and separation from protein kinase C 1989 ·Journal of Cellular Biochemistry ·Michael Gschwendt, Walter Kittstein, Friedemann Horn, (unknown), Friedrich Marks	26
18	Tumor induction in initiated mouse skin by phorbol esters and methyl methanesulfonate: correlation between chromosomal damage and conversion (‘stage I of tumor promotion’) in vivo 1989 ·Carcinogenesis ·Gerhard Fürstenberger, (unknown), Bernd Kaina, (unknown), Norbert E. Fusenig, Friedrich Marks	42
19	Effect of tumor promoting phorbol ester TPA on epidermal protein synthesis: Stimulation of an elongation factor 2 phosphatase activity by TPA in vivo 1988 ·Biochemical and Biophysical Research Communications ·Michael Gschwendt, Walter Kittstein, Friedrich Marks	13
20	Epidermal growth control mechanisms, hyperplasia, and tumor promotion in the skin. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Friedrich Marks	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact